The nation of Zimbabwe has turned down a significant US healthcare agreement worth 367 million US dollars (272 million pounds) over five years because of Washington's insistence on confidential data.
This move came to light after a government memo dated December was disclosed, which showed Head of State Emmerson Mnangagwa believed the deal was "skewed".
An official spokesperson later stated that the US was seeking health data for scientific study and profit while was not willing to guarantee the benefits from any future treatments.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
The US Embassy noted the United States had donated over $1.9bn for health programmes to Zimbabwe during the past two decades.
A doctors' association in Zimbabwe has urged more negotiations to secure a agreement acceptable to both sides so the country's vital HIV programme can continue.
Wider Context
This development follows a comparable case in Kenya, where a high court suspended a similar deal with the US after concerns were raised about the safety of Kenyans' health data.
After returning to office recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
The agency had administered aid for the American government, but Trump claimed its expenditure was "wasteful" and his administration was seeking government-to-government deals to boost openness and accountability.
According to statements, 16 African countries have to date signed these new agreements, representing more than $18.3bn in new funding.
Specifics of the Rejected Deal
The funds for Zimbabwe was intended to supported "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"We are confident this partnership might have yielded extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million presently receiving HIV treatment via US-supported programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "unfair".
"Our nation was requested to surrender its genetic material and health information for a long time, with no corresponding promise of benefiting from any medical innovations – like new medicines or tests – that might result from that provided information," he stated.
"Effectively, our nation would supply the raw materials for medical research with no assurance that the resulting innovations would be accessible to our citizens if a future pandemic emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the global health body and its push of one-on-one deals were undermining systems already established through the international health agency.
Mangwana cited its Pandemic Benefit-Sharing scheme created to manage potential pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
The government's concerns over the US deal "are not meant as anti-American sentiment," he added.
"We encourage further discussions with our US partners on how subsequent collaboration could be designed in a manner that honours the independence and dignity of each country."
Medical Community Reaction
Medical experts expressed it acknowledged the government's concerns, but urged that negotiations should continue given that much of the country's Aids initiatives depended on foreign aid.
"If specific concerns arise, including those relating to data governance or implementation frameworks, these can often be addressed via technical clarification and negotiated safeguards," the group said.
This impasse highlights the ongoing tensions between receiving vital international aid and protecting a country's data in an ever more interconnected world.